We just launched the Research Topic on 'Advancements in Therapeutic Strategies for #Skeletal#Muscle and #Cardiovascular Diseases'.
You can now easily and quickly submit manuscripts directly to Frontiers in Pharmacology: ๐ https://t.co/f26l3tBM3p
Check out this article from @biospace on some recently approved #genetherapy + #celltherapy treatments, and learn what's coming up this year. https://t.co/uH2mphOtFs
Oportunidade no nosso grupo! Se voce รฉ um aluno entusiasmado pela รกrea da Terapia Gรชnica, venha fazer parte do nosso grupo! #oportunidade#mestrado#doutorado https://t.co/PN5UamzFWJ
Quer saber mais sobre como usar o vรญrus herpes para terapia gรชnica? Leia esse post do @gene.tips #terapiagenica#ciencia#genetica https://t.co/OxK6K4PZsQ
Very proud to share the final paper from @MLGASeixas We have tested two 3D models to study the SARS-CoV-2 replication. #COVID19#biomaterials@sciencedirect https://t.co/Zn79zeFMTK
(1/3)๐ฌ๐ข Excited to share our lasted work @shahinshamsucd@UCDavisCOE@UCDavisBMEGG, @ROBERTASESSA. Harnessing the power of HIF-1ฮฑ, the "proangiogenic master pathway", we are paving a promising path in therapeutic angiogenesis for chronic vascular diseases. ๐งฌ #Angiogenesis
Only 2 days left to apply - the deadline is April 15, 2023! ๐ฃ Seeking a diverse range of candidates for fully funded positions. ๐๐ Sneak peek of our amazing work environment included! ๐ธ Don't miss out; join us at @UniStavanger@silvalabUiS. ๐ #PhD#opportunity#ApplyNow
Today, the FDA approved the FIRST #genetherapy to treat adults with Hemophilia Bโ#Hemgenix (etranacogene dezaparvovec)! Learn more about the treatment from ASGCT President @HPKiem, MD, PhD: https://t.co/5pARmY3EPg.
Happy to share that my student @Lucas_Mitre_ won one more prize (Best poster at XII Congress of ABTCel-Gen)!!!! Amazing work about tissue engineering using alginate hydrogels for muscle regeneration!!! A collaboration with @silvalabUCDavis #science#tissueengineering#alginate